Overview
No overview information available.
Background
No background information available.
Indication
用于：1.高钙血症；2.Paget病；3.骨质疏松症；4.甲状旁腺功能亢进症。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Etidronate Disodium Tablets | 国药准字H19990273 | 化学药品 | 片剂 | 6/3/2020 | |
| Etidronate Disodium Tablets | 国药准字H19990196 | 化学药品 | 片剂 | 8/5/2020 | |
| Etidronate Disodium Tablets | 国药准字H10980065 | 化学药品 | 片剂 | 11/26/2020 | |
| Etidronate Disodium Tablets | 国药准字H10970034 | 化学药品 | 片剂 | 8/13/2020 | |
| Etidronate Disodium Capsules | 国药准字H19990274 | 化学药品 | 胶囊剂 | 6/3/2020 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| Etidronate Disodium Tablets 400 mg USP Bulk | 202287 | Medicine | A | 10/25/2012 |